Clinical Trial Update: Tolerance and Effect on Intraocular Pressure After Administration of SYL040012 [Phase 1]

View source ↗

Summary

Phase 1 trial assessing tolerability and intraocular pressure effects of SYL040012 in ocular hypertension and glaucoma; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• SYL040012

Snippet

Sponsor: Sylentis, S.A. | Conditions: Ocular Hypertension, Glaucoma | Phase 1 | Status: COMPLETED